US Patent Issued to Enable Biosciences on Feb. 17 for "Multiplex competition assay for profiling binding epitopes of affinity agents for clinical diagnostics use" (California Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,553,893, issued on Feb. 17, was assigned to Enable Biosciences Inc. (South San Francisco, Calif.).

"Multiplex competition assay for profiling binding epitopes of affinity agents for clinical diagnostics use" was invented by Cheng-Ting Tsai (South San Francisco, Calif.) and Peter Robinson (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Some embodiments of the systems and methods provided herein relate to an assay. Some such embodiments include multiplex affinity probes and an antigen probe. multiplex affinity probes and an antigen probe Some embodiments include contacting a biological sample with the probes, wherein target bin...